Moderately elevated blood pressure. A report from SBU, the Swedish Council on Technology Assessment in Health Care.
D000367:Age Factors; D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D001795:Blood Pressure Determination; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003627:Data Interpretation, Statistical; D014943:Global Health; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000517:prevention & control; D007668:Kidney / Q000503:physiopathology; D008055:Lipids / Q000097:blood; D015201:Meta-Analysis as Topic; D011788:Quality of Life; D012306:Risk; D012307:Risk Factors; D012737:Sex Factors; D013548:Sweden; D014944:World Health Organization
D000959:Antihypertensive Agents; D001786:Blood Glucose; D008055:Lipids